Works matching DE "PINDOLOL"

Results: 31

Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2015, v. 30, n. 3, p. 132, doi. 10.1002/hup.2465

By:

Liu, Yiyun;
Zhou, Xinyu;
Zhu, Dan;
Chen, Jianjun;
Qin, Bin;
Zhang, Yuqing;
Wang, Xiao;
Yang, Deyu;
Meng, Huaqing;
Luo, Qinghua;
Xie, Peng

Publication type:

Article

Blockade of 5-HT1A Receptors by (±)-Pindolol Potentiates Cortical 5-HT Outflow, but not Antidepressant-Like Activity of Paroxetine: Microdialysis and Behavioral Approaches in 5-HT1A Receptor Knockout Mice.

Published in:

Neuropsychopharmacology, 2006, v. 31, n. 10, p. 2162, doi. 10.1038/sj.npp.1301019

By:

Guilloux, Jean-Philippe;
David, Denis J. P.;
Guiard, Bruno P.;
Chenu, Franck;
Repérant, Christelle;
Toth, Miklos;
Bourin, Michel;
Gardier, Alain M.

Publication type:

Article

Development of a Sensitive and Stereoselective HPLC Method for the Analysis of Pindolol in Plasma and Pharmaceutical Products Using a Chiralpak lB Column and Fluorescence Detection.

Published in:

Scientia Pharmaceutica, 2009, v. 77, n. 1, p. 47, doi. 10.3797/scipharm.0809-04

By:

Hefnawy, Mohamed;
Kassem, Mohamed;
Abdine, Haba;
Al-Zoman, Nourah

Publication type:

Article

Differential regulation of bladder beta-adrenergic and muscarinic cholinergic receptors in experimental diabetes.

Published in:

1991

By:

Latifpour, J;
Nishimoto, T;
Marian, M J;
Yoshida, M;
Weiss, R M

Publication type:

journal article

Blockade of 5-HT2 Receptor Selectively Prevents MDMA-Induced Verbal Memory Impairment.

Published in:

Neuropsychopharmacology, 2011, v. 36, n. 9, p. 1932, doi. 10.1038/npp.2011.80

By:

van Wel, J. H. P.;
Kuypers, K. P. C.;
Theunissen, E. L.;
Bosker, W. M.;
Bakker, K.;
Ramaekers, J. G.

Publication type:

Article

A Physiological Approach to Pharmacokinetics in Chronic Kidney Disease.

Published in:

Journal of Clinical Pharmacology, 2020, v. 60, p. S52, doi. 10.1002/jcph.1713

By:

Malik, Paul R.V.;
Yeung, Cindy H.T.;
Ismaeil, Shams;
Advani, Urooj;
Djie, Sebastian;
Edginton, Andrea N.

Publication type:

Article

Nonrelevant Pharmacokinetic Drug‐Drug Interaction Between Furosemide and Pindolol Enantiomers in Hypertensive Parturient Women.

Published in:

Journal of Clinical Pharmacology, 2020, v. 60, n. 11, p. 1527, doi. 10.1002/jcph.1719

By:

Gonçalves, Paulo Vinicius Bernardes;
Moreira, Fernanda de Lima;
Benzi, Jhohann Richard de Lima;
Cavalli, Ricardo Carvalho;
Duarte, Geraldo;
Lanchote, Vera Lucia

Publication type:

Article

Does Curcumin or Pindolol Potentiate Fluoxetine's Antidepressant Effect by a Pharmacokinetic or Pharmacodynamic Interaction?

Published in:

Indian Journal of Pharmaceutical Sciences, 2014, v. 76, n. 3, p. 203

By:

MURAD, H. A. S.;
SULIAMAN, M. I.;
ABDALLAH, H.;
ABDULSATTAR, MAY

Publication type:

Article

Adrenergic receptors in inner and outer layers of human myometrium near term: characterization of beta-adrenergic receptor sites by [125I]-iodocyanopindolol binding.

Published in:

1987

By:

Breuiller, Michelle;
Rouot, Bruno;
Leroy, Marie-Josèphe;
Blot, Philippe;
Kaplan, Liliana;
Ferré, Françoise;
Breuiller, M;
Rouot, B;
Leroy, M J;
Blot, P;
Kaplan, L;
Ferré, F

Publication type:

journal article

Binding properties of beta-adrenergic receptors in oviductal smooth muscle membranes.

Published in:

1984

By:

Kleinstein, Jürgen;
Kleinstein, J

Publication type:

journal article

Augmentation Strategies in Treatment-Resistant Depression.

Published in:

Psychiatric Times, 2006, v. 23, n. 12, p. 9

By:

Joffe, Russell

Publication type:

Article

Effect of pindolol on stress-related disturbances of musical performance: preliminary communication.

Published in:

Journal of the Royal Society of Medicine, 1983, v. 76, n. 3, p. 194, doi. 10.1177/014107688307600308

By:

James, I. M.;
Burgoyne, W.;
Savage, I. Temple

Publication type:

Article

Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review.

Published in:

Journal of Psychopharmacology, 2010, v. 24, n. 4, p. 513, doi. 10.1177/0269881108097714

By:

Whale, R.;
Terao, T.;
Cowen, P.;
Freemantle, N.;
Geddes, J.

Publication type:

Article

Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA.

Published in:

Journal of Psychopharmacology, 2009, v. 23, n. 8, p. 923, doi. 10.1177/0269881108094650

By:

Heffter, F. Hasler;
Studerus, E.;
Lindner, K.;
Ludewig, S.;
Vollenweider, F. X.

Publication type:

Article

The 'dalhousie serotonin cocktail' for treatment-resistant major depressive disorder.

Published in:

2001

By:

Dursun, Serdar M.;
Devarajan, Sivakumaran;
Kutcher, Stanley;
Dursun, S M;
Devarajan, S;
Kutcher, S

Publication type:

journal article

Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.

Published in:

1998

By:

Redrobe, John P.;
Bourin, Michel;
Colombel, Marie Claude;
Baker, Glen B.;
Redrobe, J P;
Bourin, M;
Colombel, M C;
Baker, G B

Publication type:

journal article

P01-67 - 5HT1A agonist activity and the antidepressant efficacy of Lu AA21004

Published in:

2010

By:

Mayze, T.

Publication type:

Abstract

A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression.

Published in:

Nordic Journal of Psychiatry, 2012, v. 66, n. 3, p. 147, doi. 10.3109/08039488.2012.674553

By:

Martiny, Klaus;
Lunde, Marianne;
Bech, Per;
Plenge, Per

Publication type:

Article

Pindolol augmentation of selective serotonin reuptake inhibitors and clomipramine for the treatment of obsessive-compulsive disorder: A meta-analysis.

Published in:

Journal of Pharmacology & Pharmacotherapeutics, 2015, v. 6, n. 1, p. 36, doi. 10.4103/0976-500X.149144

By:

Sassano-Higgins, Sean A.;
Pato, Michele T.

Publication type:

Article

Room-temperature, phosphorimetric determination of the beta-blocking agent pindolol in pharmaceutical tablets, urine and blood serum.

Published in:

Analytical & Bioanalytical Chemistry, 2007, v. 387, n. 5, p. 1945, doi. 10.1007/s00216-006-1023-z

By:

Salinas-Castillo, A.;
Cañabate-Díaz, B.;
Segura-Carretero, A.;
Fernández-Gutiérrez, A.

Publication type:

Article

Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model.

Published in:

Neurogastroenterology & Motility, 2008, v. 20, n. 6, p. 680, doi. 10.1111/j.1365-2982.2007.01065.x

By:

O'Mahony, S.;
Chua, A. S. B.;
Quigley, E. M. M.;
Clarke, G.;
Shanahan, F.;
Keeling, P. W. N.;
Dinan, T. G.

Publication type:

Article

Low‐dose pindolol in orthostatic hypotension.

Published in:

Age & Ageing, 2001, v. 30, p. 47-a, doi. 10.1093/ageing/30.suppl_4.47-a

By:

Kausar, S.A.;
Dyer, C.;
Mackison, G.;
Kasteliz, B.B.

Publication type:

Article

No Evidence that MDMA-Induced Enhancement of Emotional Empathy Is Related to Peripheral Oxytocin Levels or 5-HT1a Receptor Activation.

Published in:

PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0100719

By:

Kuypers, Kim P. C.;
de la Torre, Rafael;
Farre, Magi;
Yubero-Lahoz, Samanta;
Dziobek, Isabel;
Van den Bos, Wouter;
Ramaekers, Johannes G.

Publication type:

Article

The 2.1 Å Resolution Structure of Cyanopindolol-Bound β1-Adrenoceptor Identifies an Intramembrane Na+ Ion that Stabilises the Ligand-Free Receptor.

Published in:

PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0092727

By:

Miller-Gallacher, Jennifer L.;
Nehmé, Rony;
Warne, Tony;
Edwards, Patricia C.;
Schertler, Gebhard F. X.;
Leslie, Andrew G. W.;
Tate, Christopher G.

Publication type:

Article

Validated Stability-Indicating HPLC Method for the Separation of Pindolol Enantiomers and Its Related Substances.

Published in:

Journal of Food & Drug Analysis, 2011, v. 19, n. 1, p. 73

By:

Pujeri, S. S.;
Khader, A. M. A.;
Seetharamappa, J.

Publication type:

Article

Chiral Separation of Beta Blocker Pindolol Enantiomers.

Published in:: LC-GC Europe, 2015, p. 26
Publication type:: Article

Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis.

Published in:

European Child & Adolescent Psychiatry, 2018, v. 27, n. 10, p. 1335, doi. 10.1007/s00787-018-1125-0

By:

Padilha, Sarah C. O. S.;
Tonin, Fernanda S.;
Borba, Helena H. L.;
Virtuoso, Suzane;
Pontarolo, Roberto

Publication type:

Article

Serotonergic Neurons of Dorsal Raphe Nucleus on the Effect of a Xanthone from Kielmeyera coriacea Stems in Behavioral Tests.

Published in:

Pharmaceutical Biology, 2008, v. 46, n. 12, p. 883, doi. 10.1080/13880200802370209

By:

Martins, Juliana V.C.;
Sela, Vânia R.;
de Oliveira, Sivonei;
Cortez, Diógenes A.G.;
Audi, Elisabeth A.

Publication type:

Article

Placental and Fetal Hemodynamics After Labetalol or Pindolol in a Sheep Model of Increased Placental Vascular Resistance and Maternal Hypertension.

Published in:

Reproductive Sciences, 2009, v. 16, n. 8, p. 749, doi. 10.1177/1933719109335068

By:

Erkinaro, Tiina;
Kavasmaa, Tomi;
Ylikauma, Laura;
Mäkikallio, Kaarin;
Haapsamo, Mervi;
Acharya, Ganesh;
Ohtonen, Pasi;
Alahuhta, Seppo;
Räsänen, Juha

Publication type:

Article

Developing new method for quantifying pindolol by sequential injection analysis.

Published in:

Journal of Analytical Chemistry, 2012, v. 67, n. 5, p. 497, doi. 10.1134/S1061934812030021

By:

Idris, Abubakr;
Elgorashe, Rafea;
Alnajjar, Ahmed

Publication type:

Article

Rational synthesis of pindolol imprinted polymer by non-covalent protocol based on computational approach.

Published in:

Journal of Molecular Modeling, 2013, v. 19, n. 8, p. 3385, doi. 10.1007/s00894-013-1856-2

By:

Tadi, Kiran;
Motghare, Ramani

Publication type:

Article

Works matching DE "PINDOLOL"

Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis.

Blockade of 5-HT<sub>1A</sub> Receptors by (±)-Pindolol Potentiates Cortical 5-HT Outflow, but not Antidepressant-Like Activity of Paroxetine: Microdialysis and Behavioral Approaches in 5-HT<sub>1A</sub> Receptor Knockout Mice.

Development of a Sensitive and Stereoselective HPLC Method for the Analysis of Pindolol in Plasma and Pharmaceutical Products Using a Chiralpak lB Column and Fluorescence Detection.

Differential regulation of bladder beta-adrenergic and muscarinic cholinergic receptors in experimental diabetes.

Blockade of 5-HT<sub>2</sub> Receptor Selectively Prevents MDMA-Induced Verbal Memory Impairment.

A Physiological Approach to Pharmacokinetics in Chronic Kidney Disease.

Nonrelevant Pharmacokinetic Drug‐Drug Interaction Between Furosemide and Pindolol Enantiomers in Hypertensive Parturient Women.

Does Curcumin or Pindolol Potentiate Fluoxetine's Antidepressant Effect by a Pharmacokinetic or Pharmacodynamic Interaction?

Adrenergic receptors in inner and outer layers of human myometrium near term: characterization of beta-adrenergic receptor sites by [125I]-iodocyanopindolol binding.

Binding properties of beta-adrenergic receptors in oviductal smooth muscle membranes.

Augmentation Strategies in Treatment-Resistant Depression.

Effect of pindolol on stress-related disturbances of musical performance: preliminary communication.

Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review.

Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA.

The 'dalhousie serotonin cocktail' for treatment-resistant major depressive disorder.

Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.

P01-67 - 5HT1A agonist activity and the antidepressant efficacy of Lu AA21004

A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression.

Pindolol augmentation of selective serotonin reuptake inhibitors and clomipramine for the treatment of obsessive-compulsive disorder: A meta-analysis.

Room-temperature, phosphorimetric determination of the beta-blocking agent pindolol in pharmaceutical tablets, urine and blood serum.

Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model.

Low‐dose pindolol in orthostatic hypotension.

No Evidence that MDMA-Induced Enhancement of Emotional Empathy Is Related to Peripheral Oxytocin Levels or 5-HT<sub>1a</sub> Receptor Activation.

The 2.1 Å Resolution Structure of Cyanopindolol-Bound β<sub>1</sub>-Adrenoceptor Identifies an Intramembrane Na<sup>+</sup> Ion that Stabilises the Ligand-Free Receptor.

Validated Stability-Indicating HPLC Method for the Separation of Pindolol Enantiomers and Its Related Substances.

Chiral Separation of Beta Blocker Pindolol Enantiomers.

Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis.

Serotonergic Neurons of Dorsal Raphe Nucleus on the Effect of a Xanthone from Kielmeyera coriacea Stems in Behavioral Tests.

Placental and Fetal Hemodynamics After Labetalol or Pindolol in a Sheep Model of Increased Placental Vascular Resistance and Maternal Hypertension.

Developing new method for quantifying pindolol by sequential injection analysis.

Rational synthesis of pindolol imprinted polymer by non-covalent protocol based on computational approach.